{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:29:56Z","timestamp":1793489396906,"version":"4.5.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/1253"],"award-info":[{"award-number":["PI20\/1253"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Departamento de Desarrollo Econ\u00f3mico, Sostenibilidad y Medio Ambiente","award":["KK-2021\/00009"],"award-info":[{"award-number":["KK-2021\/00009"]}]},{"DOI":"10.13039\/100008659","name":"European Committee for Treatment and Research in Multiple Sclerosis","doi-asserted-by":"publisher","award":["ECTRIMS Postdoctoral Research Fellowship 2023"],"award-info":[{"award-number":["ECTRIMS Postdoctoral Research Fellowship 2023"]}],"id":[{"id":"10.13039\/100008659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"crossref","award":["Predoctoral fellowship"],"award-info":[{"award-number":["Predoctoral fellowship"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The central nervous system (CNS) is integrated by glial and neuronal cells, and both release extracellular vesicles (EVs) that participate in CNS homeostasis. EVs could be one of the best candidates to operate as nanosized biological platforms for analysing multidimensional bioactive cargos, which are protected during systemic circulation of EVs. Having a window into the molecular level processes that are happening in the CNS could open a new avenue in CNS research. This raises a particular point of interest: can CNS-derived EVs in blood serve as circulating biomarkers that reflect the pathological status of neurological diseases? L1 cell adhesion molecule (L1CAM) is a widely reported biomarker to identify CNS-derived EVs in peripheral blood. However, it has been demonstrated that L1CAM is also expressed outside the CNS. Given that principal data related to neurodegenerative diseases, such as multiple sclerosis, amyotrophic lateral sclerosis, Parkinson\u2019s disease and Alzheimer\u2019s disease were obtained using L1CAM-positive EVs, efforts to overcome present challenges related to its specificity are required. In this sense, other surface biomarkers for CNS-derived EVs, such as glutamate aspartate transporter (GLAST) and myelin oligodendrocyte glycoprotein (MOG), among others, have started to be used. Establishing a panel of EV biomarkers to analyse CNS-derived EVs in blood could increase the specificity and sensitivity necessary for these types of studies. This review covers the main evidence related to CNS-derived EVs in cerebrospinal fluid and blood samples of patients with neurological diseases, focusing on the reported biomarkers and the technical possibilities for their isolation. EVs are emerging as a\u00a0mirror of brain physiopathology, reflecting both localized and systemic changes. Therefore, when the technical hindrances for EV research and clinical applications are overcome, novel disease-specific panels of EV biomarkers would be discovered to facilitate transformation from traditional medicine to personalized medicine.<\/jats:p>","DOI":"10.1186\/s40035-024-00418-9","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T05:01:54Z","timestamp":1718773314000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Central nervous system-derived extracellular vesicles: the next generation of neural circulating biomarkers?"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8806-4572","authenticated-orcid":false,"given":"Roc\u00edo del Carmen","family":"Bravo-Miana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7946-489X","authenticated-orcid":false,"given":"Jone Karmele","family":"Arizaga-Echebarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6625-5976","authenticated-orcid":false,"given":"David","family":"Otaegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"key":"418_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson III","year":"2023","unstructured":"Wilson DM III, Cookson MR, Van L, Bosch D, Zetterberg H, Holtzman DM, et al. Hallmarks of neurodegenerative diseases. Cell. 2023;186:693\u2013714.","journal-title":"Cell"},{"key":"418_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41580-022-00460-3","volume":"23","author":"G Van Niel","year":"2022","unstructured":"Van Niel G, Carter DRF, Clayton A, Lambert DW, Raposo G, Vader P. Challenges and directions in studying cell\u2013cell communication by extracellular vesicles. Nat Rev Mol Cell Biol. 2022;23:369\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"418_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.addr.2020.04.004","volume":"159","author":"OM Elsharkasy","year":"2020","unstructured":"Elsharkasy OM, Nordin JZ, Hagey DW, de Jong OG, Schiffelers RM, Andaloussi SEL, et al. Extracellular vesicles as drug delivery systems: why and how? Adv Drug Deliv Rev. 2020;159:332\u201343.","journal-title":"Adv Drug Deliv Rev"},{"key":"418_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","volume":"128","author":"M Shi","year":"2014","unstructured":"Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, et al. Plasma exosomal \u03b1-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease. Acta Neuropathol. 2014;128:639\u201350.","journal-title":"Acta Neuropathol"},{"key":"418_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2019.01.005","volume":"175","author":"M Shi","year":"2019","unstructured":"Shi M, Sheng L, Stewart T, Zabetian CP, Zhang J. New windows into the brain: Central nervous system-derived extracellular vesicles in blood. Prog Neurobiol. 2019;175:96\u2013106.","journal-title":"Prog Neurobiol"},{"key":"418_CR6","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1002\/jex2.35","volume":"1","author":"DE Gomes","year":"2022","unstructured":"Gomes DE, Witwer KW. L1CAM-associated extracellular vesicles: a systematic review of nomenclature, sources, separation, and characterization. J Extracell Biol. 2022;1:e35.","journal-title":"J Extracell Biol"},{"key":"418_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41592-021-01174-8","volume":"18","author":"M Norman","year":"2021","unstructured":"Norman M, Ter-Ovanesyan D, Trieu W, Lazarovits R, Kowal EJK, Lee JH, et al. L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma. Nat Methods. 2021;18:631\u20134.","journal-title":"Nat Methods"},{"key":"418_CR8","first-page":"eaau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science (1979). 2020;367:eaau6977.","journal-title":"Science (1979)"},{"key":"418_CR9","first-page":"9412","volume":"262","author":"E Chargaff","year":"1946","unstructured":"Chargaff E, West R. The Biological significance of the thromboplastic protein of blood. J Biol Chem. 1946;262:9412\u201320.","journal-title":"J Biol Chem"},{"key":"418_CR10","doi-asserted-by":"publisher","first-page":"9412","DOI":"10.1016\/S0021-9258(18)48095-7","volume":"262","author":"RM Johnstone","year":"1987","unstructured":"Johnstone RM, Adam M, Hammonds JR, Orro L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262:9412\u201320.","journal-title":"J Biol Chem"},{"key":"418_CR11","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nm0598-594","volume":"4","author":"L Zitvogel","year":"1998","unstructured":"Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes. Nat Med. 1998;4:594\u2013600.","journal-title":"Nat Med"},{"key":"418_CR12","doi-asserted-by":"publisher","first-page":"e12175","DOI":"10.1002\/jev2.12175","volume":"10","author":"SR Li","year":"2021","unstructured":"Li SR, Man QW, Gao X, Lin H, Wang J, Su FC, et al. Tissue-derived extracellular vesicles in cancers and non-cancer diseases: present and future. J Extracell Vesicles. 2021;10:e12175.","journal-title":"J Extracell Vesicles"},{"key":"418_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","volume":"21","author":"M Mathieu","year":"2019","unstructured":"Mathieu M, Martin-Jaular L, Lavieu G, Th\u00e9ry C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21:9\u201317.","journal-title":"Nat Cell Biol"},{"key":"418_CR14","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750.","journal-title":"J Extracell Vesicles"},{"key":"418_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41556-018-0040-4","volume":"20","author":"H Zhang","year":"2018","unstructured":"Zhang H, Freitas D, Kim HS, Fabijanic K, Li Z, Chen H, et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat Cell Biol. 2018;20:332\u201343.","journal-title":"Nat Cell Biol"},{"key":"418_CR16","first-page":"262","volume":"182","author":"F Cocozza","year":"2020","unstructured":"Cocozza F, Grisard E, Martin-Jaular L, Mathieu M, Th\u00e9ry C, SnapShot. Extracell Vesicles Cell. 2020;182:262\u2013e2621.","journal-title":"Extracell Vesicles Cell"},{"key":"418_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nrn.2015.29","volume":"17","author":"V Budnik","year":"2016","unstructured":"Budnik V, Ruiz-Ca\u00f1ada C, Wendler F. Extracellular vesicles round off communication in the nervous system. Nat Rev Neurosci. 2016;17:160\u201372.","journal-title":"Nat Rev Neurosci"},{"key":"418_CR18","doi-asserted-by":"publisher","first-page":"626043","DOI":"10.3389\/fncel.2021.626043","volume":"15","author":"Y Gassama","year":"2021","unstructured":"Gassama Y, Favereaux A. Emerging roles of extracellular vesicles in the central nervous system: physiology, pathology, and therapeutic perspectives. Front Cell Neurosci. 2021;15:626043.","journal-title":"Front Cell Neurosci"},{"key":"418_CR19","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/1873-3468.14074","volume":"595","author":"LR Lizarraga-Valderrama","year":"2021","unstructured":"Lizarraga-Valderrama LR, Sheridan GK. Extracellular vesicles and intercellular communication in the central nervous system. FEBS Lett. 2021;595:1391\u2013410.","journal-title":"FEBS Lett"},{"key":"418_CR20","doi-asserted-by":"publisher","first-page":"82195","DOI":"10.3389\/fncel.2014.00100","volume":"8","author":"M S\u00e1enz-Cuesta","year":"2014","unstructured":"S\u00e1enz-Cuesta M, Osorio-Querejeta I, Otaegui D. Extracellular vesicles in multiple sclerosis: what are they telling us? Front Cell Neurosci. 2014;8:82195.","journal-title":"Front Cell Neurosci"},{"key":"418_CR21","doi-asserted-by":"publisher","first-page":"7336","DOI":"10.3390\/ijms21197336","volume":"21","author":"E Dolcetti","year":"2020","unstructured":"Dolcetti E, Bruno A, Guadalupi L, Rizzo FR, Musella A, Gentile A, et al. Emerging role of extracellular vesicles in the pathophysiology of multiple sclerosis. Int J Mol Sci 2020. 2020;21:7336.","journal-title":"Int J Mol Sci 2020."},{"key":"418_CR22","doi-asserted-by":"publisher","first-page":"635104","DOI":"10.3389\/fcell.2021.635104","volume":"9","author":"M Beatriz","year":"2021","unstructured":"Beatriz M, Vila\u00e7a R, Lopes C, Exosomes. Innocent bystanders or critical culprits in neurodegenerative diseases. Front Cell Dev Biol. 2021;9:635104.","journal-title":"Front Cell Dev Biol"},{"key":"418_CR23","doi-asserted-by":"publisher","first-page":"871491","DOI":"10.3389\/fneur.2022.871491","volume":"13","author":"J Long","year":"2022","unstructured":"Long J, Zhang Y, Liu X, Pan M, Gao Q. Exosomes in the field of Neuroscience: a scientometric study and visualization analysis. Front Neurol. 2022;13:871491.","journal-title":"Front Neurol"},{"key":"418_CR24","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1152\/physrev.00031.2020","volume":"102","author":"MK Rasmussen","year":"2022","unstructured":"Rasmussen MK, Mestre H, Nedergaard M. Fluid transport in the brain. Physiol Rev. 2022;102:1025.","journal-title":"Physiol Rev"},{"key":"418_CR25","doi-asserted-by":"publisher","first-page":"e90429","DOI":"10.1371\/journal.pone.0090429","volume":"9","author":"E Aaseb\u00f8","year":"2014","unstructured":"Aaseb\u00f8 E, Opsahl JA, Bj\u00f8rlykke Y, Myhr KM, Kroksveen AC, Berven FS. Effects of blood contamination and the rostro-caudal gradient on the human cerebrospinal fluid proteome. PLoS ONE. 2014;9:e90429.","journal-title":"PLoS ONE"},{"key":"418_CR26","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.bbapap.2014.12.013","volume":"1854","author":"AC Kroksveen","year":"2015","unstructured":"Kroksveen AC, Opsahl JA, Guldbrandsen A, Myhr KM, Oveland E, Torkildsen, et al. Cerebrospinal fluid proteomics in multiple sclerosis. Biochim Biophys Acta. 2015;1854:746\u201356.","journal-title":"Biochim Biophys Acta"},{"key":"418_CR27","doi-asserted-by":"publisher","first-page":"e0206478","DOI":"10.1371\/journal.pone.0206478","volume":"13","author":"LM Schilde","year":"2018","unstructured":"Schilde LM, K\u00f6sters S, Steinbach S, Schork K, Eisenacher M, Galozzi S, et al. Protein variability in cerebrospinal fluid and its possible implications for neurological protein biomarker research. PLoS ONE. 2018;13:e0206478.","journal-title":"PLoS ONE"},{"key":"418_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/pmic.200400889","volume":"5","author":"JS Youl","year":"2005","unstructured":"Youl JS, Gelfanova V, Knierman MD, Witzmann FA, Wang M, Hale JE. The impact of blood contamination on the proteome of cerebrospinal fluid. Proteomics. 2005;5:290\u20136.","journal-title":"Proteomics"},{"key":"418_CR29","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"CE Teunissen","year":"2009","unstructured":"Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009;73:1914\u201322.","journal-title":"Neurology"},{"key":"418_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1479-5876-10-5","volume":"10","author":"JM Street","year":"2012","unstructured":"Street JM, Barran PE, Mackay CL, Weidt S, Balmforth C, Walsh TS, et al. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J Transl Med. 2012;10:5.","journal-title":"J Transl Med"},{"key":"418_CR31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1074\/mcp.O116.064477","volume":"16","author":"A Guldbrandsen","year":"2017","unstructured":"Guldbrandsen A, Farag Y, Kroksveen AC, Oveland E, Lereim RR, Opsahl JA, et al. CSF-PR 2.0: an interactive literature guide to quantitative cerebrospinal fluid Mass Spectrometry Data from Neurodegenerative disorders. Mol Cell Proteom. 2017;16:300\u20139.","journal-title":"Mol Cell Proteom"},{"key":"418_CR32","doi-asserted-by":"crossref","unstructured":"Alberro A, Iparraguirre L, Fernandes A, Otaegui D. Extracellular vesicles in blood: sources, effects, and applications. Int J Mol Sci. 2021;22:8163.","DOI":"10.3390\/ijms22158163"},{"key":"418_CR33","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","volume":"391","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018;391:1622\u201336.","journal-title":"Lancet"},{"key":"418_CR34","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3233\/JAD-160484","volume":"54","author":"P Maresova","year":"2016","unstructured":"Maresova P, Klimova B, Novotny M, Kuca K. Alzheimer\u2019s and Parkinson\u2019s diseases: Expected Economic Impact on Europe\u2014A call for a uniform European strategy. J Alzheimers Dis. 2016;54:1123\u201333.","journal-title":"J Alzheimers Dis"},{"key":"418_CR35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, Cutter GR, S\u00f8rensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis. Neurology. 2014;83:278\u201386.","journal-title":"Neurology"},{"key":"418_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, et al. Multiple sclerosis. Nat Rev Dis Primers. 2018;4:43.","journal-title":"Nat Rev Dis Primers"},{"key":"418_CR37","doi-asserted-by":"publisher","first-page":"175628641987832","DOI":"10.1177\/1756286419878323","volume":"12","author":"S Faissner","year":"2019","unstructured":"Faissner S, Gold R. Progressive multiple sclerosis: latest therapeutic developments and future directions. Ther Adv Neurol Disord. 2019;12:1756286419878323.","journal-title":"Ther Adv Neurol Disord"},{"key":"418_CR38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292\u2013302.","journal-title":"Ann Neurol"},{"key":"418_CR39","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cca.2016.09.001","volume":"462","author":"J Lee","year":"2016","unstructured":"Lee J, McKinney KQ, Pavlopoulos AJ, Han MH, Kim SH, Kim HJ, et al. Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis. Clin Chim Acta. 2016;462:118\u201326.","journal-title":"Clin Chim Acta"},{"key":"418_CR40","doi-asserted-by":"publisher","first-page":"1369805","DOI":"10.1080\/20013078.2017.1369805","volume":"6","author":"JL Welton","year":"2017","unstructured":"Welton JL, Loveless S, Stone T, von Ruhland C, Robertson NP, Clayton A. Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis. J Extracell Vesicles. 2017;6:1369805.","journal-title":"J Extracell Vesicles"},{"key":"418_CR41","doi-asserted-by":"publisher","first-page":"398513","DOI":"10.3389\/fncel.2018.00418","volume":"12","author":"F Geraci","year":"2018","unstructured":"Geraci F, Ragonese P, Barreca MM, Aliotta E, Mazzola MA, Realmuto S, et al. Differences in intercellular communication during clinical relapse and gadolinium-enhanced MRI in patients with relapsing remitting multiple sclerosis: a study of the composition of extracellular vesicles in cerebrospinal fluid. Front Cell Neurosci. 2018;12:398513.","journal-title":"Front Cell Neurosci"},{"key":"418_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ana.26154","volume":"90","author":"S Gelibter","year":"2021","unstructured":"Gelibter S, Pisa M, Croese T, Finardi A, Mandelli A, Sangalli F, et al. Spinal fluid myeloid microvesicles predict disease course in multiple sclerosis. Ann Neurol. 2021;90:253\u201365.","journal-title":"Ann Neurol"},{"key":"418_CR43","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1177\/1352458520987542","volume":"27","author":"G Dalla Costa","year":"2021","unstructured":"Dalla Costa G, Croese T, Pisa M, Finardi A, Fabbella L, Martinelli V, et al. CSF extracellular vesicles and risk of disease activity after a first demyelinating event. Mult Scler. 2021;27:1606\u201310.","journal-title":"Mult Scler"},{"key":"418_CR44","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/1352458520924590","volume":"27","author":"P Bhargava","year":"2021","unstructured":"Bhargava P, Nogueras-Ortiz C, Kim S, Delgado-Peraza F, Calabresi PA, Kapogiannis D. Synaptic and complement markers in Extracellular vesicles in multiple sclerosis. Mult Scler. 2021;27:509\u201318.","journal-title":"Mult Scler"},{"key":"418_CR45","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3390\/cells11091551","volume":"11","author":"F Scaroni","year":"2022","unstructured":"Scaroni F, Visconte C, Serpente M, Golia MT, Gabrielli M, Huiskamp M, et al. Mir-150-5p and let-7b-5p in blood myeloid extracellular vesicles Track cognitive symptoms in patients with multiple sclerosis. Cells. 2022;11:1551.","journal-title":"Cells"},{"key":"418_CR46","doi-asserted-by":"publisher","first-page":"894","DOI":"10.3390\/ijms24010894","volume":"24","author":"C Agliardi","year":"2023","unstructured":"Agliardi C, Guerini FR, Zanzottera M, Bolognesi E, Picciolini S, Caputo D, et al. Myelin Basic protein in oligodendrocyte-derived extracellular vesicles as a diagnostic and prognostic biomarker in multiple sclerosis: a pilot study. Int J Mol Sci. 2023;24:894.","journal-title":"Int J Mol Sci"},{"key":"418_CR47","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00018-020-03619-3","volume":"78","author":"D Gagliardi","year":"2021","unstructured":"Gagliardi D, Bresolin N, Comi G, Pietro, Corti S. Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers. Cell Mol Life Sci. 2021;78:561\u201372.","journal-title":"Cell Mol Life Sci"},{"key":"418_CR48","doi-asserted-by":"publisher","first-page":"24178","DOI":"10.18632\/oncotarget.4680","volume":"6","author":"X Ding","year":"2015","unstructured":"Ding X, Ma M, Teng J, Teng RKF, Zhou S, Yin J, et al. Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure. Oncotarget. 2015;6:24178\u201391.","journal-title":"Oncotarget"},{"key":"418_CR49","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/21678421.2014.905606","volume":"15","author":"E Feneberg","year":"2014","unstructured":"Feneberg E, Steinacker P, Lehnert S, Schneider A, Walther P, Thal DR, et al. Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:351\u20136.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"418_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12014-020-09294-7","volume":"17","author":"AG Thompson","year":"2020","unstructured":"Thompson AG, Gray E, M\u00e4ger I, Th\u00e9z\u00e9nas ML, Charles PD, Talbot K, et al. CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis. Clin Proteom. 2020;17:31.","journal-title":"Clin Proteom"},{"key":"418_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neures.2019.10.010","volume":"160","author":"N Hayashi","year":"2020","unstructured":"Hayashi N, Doi H, Kurata Y, Kagawa H, Atobe Y, Funakoshi K, et al. Proteomic analysis of exosome-enriched fractions derived from cerebrospinal fluid of amyotrophic lateral sclerosis patients. Neurosci Res. 2020;160:43\u20139.","journal-title":"Neurosci Res"},{"key":"418_CR52","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bbrc.2022.04.127","volume":"613","author":"S Sjoqvist","year":"2022","unstructured":"Sjoqvist S, Otake K. A pilot study using proximity extension assay of cerebrospinal fluid and its extracellular vesicles identifies novel amyotrophic lateral sclerosis biomarker candidates. Biochem Biophys Res Commun. 2022;613:166\u201373.","journal-title":"Biochem Biophys Res Commun"},{"key":"418_CR53","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/genes14020325","volume":"14","author":"M Barbo","year":"2023","unstructured":"Barbo M, Ravnik-Glava\u010d M. Extracellular vesicles as potential biomarkers in amyotrophic lateral sclerosis. Genes (Basel). 2023;14:325.","journal-title":"Genes (Basel)"},{"key":"418_CR54","doi-asserted-by":"publisher","first-page":"134176","DOI":"10.1016\/j.neulet.2019.03.048","volume":"708","author":"M Katsu","year":"2019","unstructured":"Katsu M, Hama Y, Utsumi J, Takashina K, Yasumatsu H, Mori F, et al. MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis. Neurosci Lett. 2019;708:134176.","journal-title":"Neurosci Lett"},{"key":"418_CR55","doi-asserted-by":"publisher","first-page":"200116","DOI":"10.1098\/rsob.200116","volume":"10","author":"SA Banack","year":"2020","unstructured":"Banack SA, Dunlop RA, Cox PA. An miRNA fingerprint using neural-enriched extracellular vesicles from blood plasma: towards a biomarker for amyotrophic lateral sclerosis\/motor neuron disease. Open Biol. 2020;10:200116.","journal-title":"Open Biol"},{"key":"418_CR56","doi-asserted-by":"publisher","first-page":"120396","DOI":"10.1016\/j.jns.2022.120396","volume":"442","author":"SA Banack","year":"2022","unstructured":"Banack SA, Dunlop RA, Stommel EW, Mehta P, Cox PA. miRNA extracted from extracellular vesicles is a robust biomarker of amyotrophic lateral sclerosis. J Neurol Sci. 2022;442:120396.","journal-title":"J Neurol Sci"},{"key":"418_CR57","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1093\/brain\/awac115","volume":"145","author":"A Kluge","year":"2022","unstructured":"Kluge A, Bunk J, Schaeffer E, Drobny A, Xiang W, Knacke H, et al. Detection of neuron-derived pathological \u03b1-synuclein in blood. Brain. 2022;145:3058\u201371.","journal-title":"Brain"},{"key":"418_CR58","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neuroscience.2022.11.017","volume":"511","author":"K Wang","year":"2023","unstructured":"Wang K, Shen J, Xu Y. An update on peripheral blood extracellular vesicles as biomarkers for Parkinson\u2019s Disease diagnosis. Neuroscience. 2023;511:131\u201346.","journal-title":"Neuroscience"},{"key":"418_CR59","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/brain\/awv346","volume":"139","author":"A Stuendl","year":"2016","unstructured":"Stuendl A, Kunadt M, Kruse N, Bartels C, Moebius W, Danzer KM, et al. Induction of \u03b1-synuclein aggregate formation by CSF exosomes from patients with Parkinson\u2019s disease and dementia with Lewy bodies. Brain. 2016;139:481\u201394.","journal-title":"Brain"},{"key":"418_CR60","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/15548627.2017.1395992","volume":"14","author":"G Minakaki","year":"2018","unstructured":"Minakaki G, Menges S, Kittel A, Emmanouilidou E, Schaeffner I, Barkovits K, et al. Autophagy inhibition promotes SNCA\/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype. Autophagy. 2018;14:98\u2013119.","journal-title":"Autophagy"},{"key":"418_CR61","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/brain\/awac261","volume":"146","author":"S Herman","year":"2023","unstructured":"Herman S, Djaldetti R, Mollenhauer B, Offen D. CSF-derived extracellular vesicles from patients with Parkinson\u2019s disease induce symptoms and pathology. Brain. 2023;146:209\u201324.","journal-title":"Brain"},{"key":"418_CR62","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/brain\/awaa090","volume":"143","author":"M Guo","year":"2020","unstructured":"Guo M, Wang J, Zhao Y, Feng Y, Han S, Dong Q, et al. Microglial exosomes facilitate \u03b1-synuclein transmission in Parkinson\u2019s disease. Brain. 2020;143:1476\u201397.","journal-title":"Brain"},{"key":"418_CR63","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/biomedicines9030230","volume":"9","author":"E Vacchi","year":"2021","unstructured":"Vacchi E, Burrello J, Burrello A, Bolis S, Monticone S, Barile L, et al. Profiling inflammatory extracellular vesicles in plasma and cerebrospinal fluid: an optimized diagnostic model for Parkinson\u2019s Disease. Biomedicines. 2021;9:230.","journal-title":"Biomedicines"},{"key":"418_CR64","doi-asserted-by":"publisher","first-page":"e2332","DOI":"10.1212\/WNL.0000000000011853","volume":"96","author":"Z Hong","year":"2021","unstructured":"Hong Z, Tian C, Stewart T, Aro P, Soltys D, Bercow M, et al. Development of a sensitive diagnostic assay for Parkinson Disease quantifying \u03b1-Synuclein\u2013containing extracellular vesicles. Neurology. 2021;96:e2332\u201345.","journal-title":"Neurology"},{"key":"418_CR65","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1002\/mds.26686","volume":"31","author":"KB Fraser","year":"2016","unstructured":"Fraser KB, Rawlins AB, Clark RG, Alcalay RN, Standaert DG, Liu N, et al. Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson\u2019s disease. Mov Disord. 2016;31:1543\u201350.","journal-title":"Mov Disord"},{"key":"418_CR66","doi-asserted-by":"publisher","first-page":"539855","DOI":"10.3389\/fnins.2020.00526","volume":"14","author":"OS Mabrouk","year":"2020","unstructured":"Mabrouk OS, Chen S, Edwards AL, Yang M, Hirst WD, Graham DL. Quantitative measurements of LRRK2 in human cerebrospinal fluid demonstrates increased levels in G2019S patients. Front Neurosci. 2020;14:539855.","journal-title":"Front Neurosci"},{"key":"418_CR67","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jalz.2016.04.003","volume":"12","author":"M Shi","year":"2016","unstructured":"Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, et al. CNS tau efflux via exosomes is likely increased in Parkinson\u2019s disease but not in Alzheimer\u2019s disease. Alzheimers Dement. 2016;12:1125\u201331.","journal-title":"Alzheimers Dement"},{"key":"418_CR68","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neuroscience.2019.05.015","volume":"413","author":"X Si","year":"2019","unstructured":"Si X, Tian J, Chen Y, Yan Y, Pu J, Zhang B. Central nervous system-derived exosomal alpha-synuclein in serum may be a biomarker in Parkinson\u2019s disease. Neuroscience. 2019;413:308\u201316.","journal-title":"Neuroscience"},{"key":"418_CR69","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/ene.14208","volume":"27","author":"M Niu","year":"2020","unstructured":"Niu M, Li Y, Li G, Zhou L, Luo N, Yao M, et al. A longitudinal study on \u03b1-synuclein in plasma neuronal exosomes as a biomarker for Parkinson\u2019s disease development and progression. Eur J Neurol. 2020;27:967\u201374.","journal-title":"Eur J Neurol"},{"key":"418_CR70","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/jnnp-2019-322588","volume":"91","author":"C Jiang","year":"2020","unstructured":"Jiang C, Hopfner F, Katsikoudi A, Hein R, Catli C, Evetts S, et al. Original research: serum neuronal exosomes predict and differentiate Parkinson\u2019s disease from atypical parkinsonism. J Neurol Neurosurg Psychiatry. 2020;91:720\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"418_CR71","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s13311-020-00842-5","volume":"17","author":"J Zou","year":"2020","unstructured":"Zou J, Guo Y, Wei L, Yu F, Yu B, Xu A. Long noncoding RNA POU3F3 and \u03b1-Synuclein in plasma L1CAM exosomes combined with \u03b2-Glucocerebrosidase activity: potential predictors of Parkinson\u2019s Disease. Neurotherapeutics. 2020;17:1104\u201319.","journal-title":"Neurotherapeutics"},{"key":"418_CR72","doi-asserted-by":"publisher","first-page":"13647","DOI":"10.1021\/acs.analchem.0c03092","volume":"92","author":"Y Fu","year":"2020","unstructured":"Fu Y, Jiang C, Tofaris GK, Davis JJ. Facile impedimetric analysis of neuronal exosome markers in Parkinson\u2019s disease diagnostics. Anal Chem. 2020;92:13647\u201351.","journal-title":"Anal Chem"},{"key":"418_CR73","doi-asserted-by":"publisher","first-page":"564641","DOI":"10.3389\/fcell.2020.564641","volume":"8","author":"SY Chou","year":"2020","unstructured":"Chou SY, Chan L, Chung CC, Chiu JY, Hsieh YC, Hong CT. Altered insulin receptor substrate 1 phosphorylation in blood neuron-derived extracellular vesicles from patients with Parkinson\u2019s Disease. Front Cell Dev Biol. 2020;8:564641.","journal-title":"Front Cell Dev Biol"},{"key":"418_CR74","doi-asserted-by":"publisher","first-page":"105185","DOI":"10.1016\/j.nbd.2020.105185","volume":"148","author":"C Agliardi","year":"2021","unstructured":"Agliardi C, Meloni M, Guerini FR, Zanzottera M, Bolognesi E, Baglio F, et al. Oligomeric \u03b1-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson\u2019s disease. Neurobiol Dis. 2021;148:105185.","journal-title":"Neurobiol Dis"},{"key":"418_CR75","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00401-021-02324-0","volume":"142","author":"S Dutta","year":"2021","unstructured":"Dutta S, Hornung S, Kruayatidee A, Maina KN, del Rosario I, Paul KC, et al. \u03b1-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson\u2019s disease from multiple system atrophy. Acta Neuropathol. 2021;142:495\u2013511.","journal-title":"Acta Neuropathol"},{"key":"418_CR76","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1002\/mds.28591","volume":"36","author":"C Jiang","year":"2021","unstructured":"Jiang C, Hopfner F, Berg D, Hu MT, Pilotto A, Borroni B, et al. Validation of \u03b1-Synuclein in L1CAM-Immunocaptured exosomes as a biomarker for the stratification of parkinsonian syndromes. Mov Disord. 2021;36:2663\u20139.","journal-title":"Mov Disord"},{"key":"418_CR77","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jamaneurol.2023.4398","volume":"81","author":"S Yan","year":"2024","unstructured":"Yan S, Jiang C, Janzen A, Barber TR, Seger A, Sommerauer M, et al. Neuronally derived Extracellular Vesicle \u03b1-Synuclein as a serum biomarker for individuals at risk of developing Parkinson Disease Supplemental content. JAMA Neurol. 2024;81:59\u201368.","journal-title":"JAMA Neurol"},{"key":"418_CR78","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","volume":"11","author":"MS Fiandaca","year":"2015","unstructured":"Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, et al. Identification of preclinical Alzheimer\u2019s disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimers Dement. 2015;11:600\u20137.e1.","journal-title":"Alzheimers Dement."},{"key":"418_CR79","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/10408363.2017.1299682","volume":"54","author":"P Bastos","year":"2017","unstructured":"Bastos P, Ferreira R, Manadas B, Moreira PI, Vitorino R. Insights into the human brain proteome: disclosing the biological meaning of protein networks in cerebrospinal fluid. Crit Rev Clin Lab Sci. 2017;54:185\u2013204.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"418_CR80","doi-asserted-by":"publisher","first-page":"623","DOI":"10.4161\/cib.21437","volume":"5","author":"GF Hall","year":"2012","unstructured":"Hall GF, Saman S. Death or secretion? The demise of a plausible assumption about CSF-tau in Alzheimer Disease? Commun Integr Biol. 2012;5:623\u20136.","journal-title":"Commun Integr Biol"},{"key":"418_CR81","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1074\/jbc.M111.277061","volume":"287","author":"S Saman","year":"2012","unstructured":"Saman S, Kim WH, Raya M, Visnick Y, Miro S, Saman S, et al. Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem. 2012;287:3842\u20139.","journal-title":"J Biol Chem"},{"key":"418_CR82","doi-asserted-by":"publisher","first-page":"7089","DOI":"10.1038\/s41598-019-43607-7","volume":"9","author":"P Spitzer","year":"2019","unstructured":"Spitzer P, Mulzer LM, Oberstein TJ, Munoz LE, Lewczuk P, Kornhuber J, et al. Microvesicles from cerebrospinal fluid of patients with Alzheimer\u2019s disease display reduced concentrations of tau and APP protein. Sci Rep. 2019;9:7089.","journal-title":"Sci Rep"},{"key":"418_CR83","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1038\/emboj.2011.376","volume":"30","author":"X Li","year":"2011","unstructured":"Li X, Kumar Y, Zempel H, Mandelkow EM, Biernat J, Mandelkow E. Novel diffusion barrier for axonal retention of tau in neurons and its failure in neurodegeneration. EMBO J. 2011;30:4825\u201337.","journal-title":"EMBO J"},{"key":"418_CR84","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.bbamcr.2015.03.003","volume":"1853","author":"Z Tang","year":"2015","unstructured":"Tang Z, Ioja E, Bereczki E, Hultenby K, Li C, Guan Z, et al. mTor mediates tau localization and secretion: implication for Alzheimer\u2019s disease. Biochim Biophys Acta. 2015;1853:1646\u201357.","journal-title":"Biochim Biophys Acta"},{"key":"418_CR85","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3390\/cells9091959","volume":"9","author":"S Muraoka","year":"2020","unstructured":"Muraoka S, Jedrychowski MP, Yanamandra K, Ikezu S, Gygi SP, Ikezu T. Proteomic profiling of Extracellular vesicles derived from Cerebrospinal Fluid of Alzheimer\u2019s Disease patients: a pilot study. Cells. 2020;9:1959.","journal-title":"Cells"},{"key":"418_CR86","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3390\/cells11030462","volume":"11","author":"A Longobardi","year":"2022","unstructured":"Longobardi A, Nicsanu R, Bellini S, Squitti R, Catania M, Tiraboschi P, et al. Cerebrospinal Fluid EV concentration and size are altered in Alzheimer\u2019s Disease and Dementia with Lewy Bodies. Cells. 2022;11:462.","journal-title":"Cells"},{"key":"418_CR87","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/cdd.2013.180","volume":"21","author":"P Joshi","year":"2014","unstructured":"Joshi P, Turola E, Ruiz A, Bergami A, Libera DD, Benussi L, et al. Microglia convert aggregated amyloid-\u03b2 into neurotoxic forms through the shedding of microvesicles. Cell Death Diff. 2014;21:582\u201393.","journal-title":"Cell Death Diff"},{"key":"418_CR88","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fphys.2012.00229","volume":"3","author":"V Vingtdeux","year":"2012","unstructured":"Vingtdeux V, Sergeant N, Bu\u00e9e L. Potential contribution of exosomes to the prion-like propagation of lesions in Alzheimer\u2019s disease. Front Physiol. 2012;3:229.","journal-title":"Front Physiol"},{"key":"418_CR89","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semcdb.2015.02.007","volume":"40","author":"BM Coleman","year":"2015","unstructured":"Coleman BM, Hill AF. Extracellular vesicles \u2013 their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases. Semin Cell Dev Biol. 2015;40:89\u201396.","journal-title":"Semin Cell Dev Biol"},{"key":"418_CR90","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/ana.24235","volume":"76","author":"F Agosta","year":"2014","unstructured":"Agosta F, Libera DD, Spinelli EG, Finardi A, Canu E, Bergami A, et al. Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease. Ann Neurol. 2014;76:813\u201325.","journal-title":"Ann Neurol"},{"key":"418_CR91","doi-asserted-by":"publisher","first-page":"682115","DOI":"10.3389\/fnagi.2021.682115","volume":"13","author":"J Utz","year":"2021","unstructured":"Utz J, Berner J, Mu\u00f1oz LE, Oberstein TJ, Kornhuber J, Herrmann M, et al. Cerebrospinal fluid of patients with Alzheimer\u2019s disease contains increased percentages of synaptophysin-bearing microvesicles. Front Aging Neurosci. 2021;13:682115.","journal-title":"Front Aging Neurosci"},{"key":"418_CR92","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1096\/fj.14-262048","volume":"29","author":"D Kapogiannis","year":"2015","unstructured":"Kapogiannis D, Boxer A, Schwartz JB, Abner EL, Biragyn A, Masharani U, et al. Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer\u2019s disease. FASEB J. 2015;29:589\u201396.","journal-title":"FASEB J"},{"key":"418_CR93","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1212\/WNL.0000000000001702","volume":"85","author":"EJ Goetzl","year":"2015","unstructured":"Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, et al. Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology. 2015;85:40\u20137.","journal-title":"Neurology"},{"key":"418_CR94","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.dadm.2016.04.001","volume":"3","author":"CN Winston","year":"2016","unstructured":"Winston CN, Goetzl EJ, Akers JC, Carter BS, Rockenstein EM, Galasko D, et al. Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile. Alzheimers Dement (Amst). 2016;3:63\u201372.","journal-title":"Alzheimers Dement (Amst)"},{"key":"418_CR95","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1096\/fj.201600756R","volume":"30","author":"EJ Goetzl","year":"2016","unstructured":"Goetzl EJ, Mustapic M, Kapogiannis D, Eitan E, Lobach IV, Goetzl L, et al. Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer\u2019s disease. FASEB J. 2016;30:3853\u20139.","journal-title":"FASEB J"},{"key":"418_CR96","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1096\/fj.201600816R","volume":"30","author":"EJ Goetzl","year":"2016","unstructured":"Goetzl EJ, Kapogiannis D, Schwartz JB, Lobach IV, Goetzl L, Abner EL, et al. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer\u2019s disease. FASEB J. 2016;30:4141\u20138.","journal-title":"FASEB J"},{"key":"418_CR97","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ana.25172","volume":"83","author":"EJ Goetzl","year":"2018","unstructured":"Goetzl EJ, Schwartz JB, Abner EL, Jicha GA, Kapogiannis D. High complement levels in astrocyte-derived exosomes of Alzheimer\u2019s disease. Ann Neurol. 2018;83:544\u201352.","journal-title":"Ann Neurol"},{"key":"418_CR98","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1096\/fj.201801001","volume":"33","author":"EJ Goetzl","year":"2019","unstructured":"Goetzl EJ, Nogueras-Ortiz C, Mustapic M, Mullins RJ, Abner EL, Schwartz JB, et al. Deficient neurotrophic factors of CSPG4-type neural cell exosomes in Alzheimer disease. FASEB J. 2019;33:231\u20138.","journal-title":"FASEB J"},{"key":"418_CR99","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.1007\/s12035-019-1501-x","volume":"56","author":"C Agliardi","year":"2019","unstructured":"Agliardi C, Guerini FR, Zanzottera M, Bianchi A, Nemni R, Clerici M. SNAP-25 in serum is carried by exosomes of neuronal origin and is a potential biomarker of Alzheimer\u2019s Disease. Mol Neurobiol. 2019;56:5792\u20138.","journal-title":"Mol Neurobiol"},{"key":"418_CR100","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jalz.2019.05.002","volume":"15","author":"L Jia","year":"2019","unstructured":"Jia L, Qiu Q, Zhang H, Chu L, Du Y, Zhang J, et al. Concordance between the assessment of A\u03b242, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid. Alzheimers Dement. 2019;15:1071\u201380.","journal-title":"Alzheimers Dement"},{"key":"418_CR101","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3389\/fnins.2019.01208","volume":"13","author":"DJ Cha","year":"2019","unstructured":"Cha DJ, Mengel D, Mustapic M, Liu W, Selkoe DJ, Kapogiannis D, et al. miR-212 and miR-132 are downregulated in Neurally Derived plasma exosomes of Alzheimer\u2019s patients. Front Neurosci. 2019;13:1208.","journal-title":"Front Neurosci"},{"key":"418_CR102","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3390\/cells9061443","volume":"9","author":"M Serpente","year":"2020","unstructured":"Serpente M, Fenoglio C, D\u2019Anca M, Arcaro M, Sorrentino F, Visconte C, et al. MiRNA Profiling in plasma neural-derived small extracellular vesicles from patients with Alzheimer\u2019s Disease. Cells. 2020;9:1443.","journal-title":"Cells"},{"key":"418_CR103","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/acn3.51155","volume":"7","author":"D Gu","year":"2020","unstructured":"Gu D, Liu F, Meng M, Zhang L, Gordon ML, Wang Y, et al. Elevated matrix metalloproteinase-9 levels in neuronal extracellular vesicles in Alzheimer\u2019s disease. Ann Clin Transl Neurol. 2020;7:1681\u201391.","journal-title":"Ann Clin Transl Neurol"},{"key":"418_CR104","first-page":"19","volume":"34","author":"LC Geng","year":"2021","unstructured":"Geng LC, Shuang M, Ying L, Yao L, Yue Z, Chang WP, et al. MicroRNA-135a in ABCA1-labeled exosome is a serum biomarker candidate for Alzheimer\u2019s disease. Biomed Environ Sci. 2021;34:19\u201328.","journal-title":"Biomed Environ Sci"},{"key":"418_CR105","first-page":"5450397","volume":"2021","author":"CG Liu","year":"2021","unstructured":"Liu CG, Zhao Y, Lu Y, Wang PC. ABCA1-labeled exosomes in serum contain higher microRNA-193b levels in Alzheimer\u2019s disease. Biomed Res Int. 2021;2021:5450397.","journal-title":"Biomed Res Int"},{"key":"418_CR106","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13195-022-01010-x","volume":"14","author":"TR Li","year":"2022","unstructured":"Li TR, Yao YX, Jiang XY, Dong QY, Yu XF, Wang T, et al. \u03b2-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer\u2019s disease and predicts cerebral amyloidosis. Alzheimers Res Ther. 2022;14:66.","journal-title":"Alzheimers Res Ther"},{"key":"418_CR107","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1007\/s12031-022-02012-y","volume":"72","author":"DY Durur","year":"2022","unstructured":"Durur DY, Tastan B, Ugur Tufekci K, Olcum M, Uzuner H, Karak\u00fclah G, et al. Alteration of miRNAs in small neuron-derived extracellular vesicles of Alzheimer\u2019s disease patients and the effect of extracellular vesicles on microglial immune responses. J Mol Neurosci. 2022;72:1182\u201394.","journal-title":"J Mol Neurosci"},{"key":"418_CR108","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/cns.13846","volume":"28","author":"Y Li","year":"2022","unstructured":"Li Y, Meng S, Di W, Xia M, Dong L, Zhao Y, et al. Amyloid-\u03b2 protein and MicroRNA\u2010384 in NCAM\u2010Labeled exosomes from peripheral blood are potential diagnostic markers for Alzheimer\u2019s disease. CNS Neurosci Ther. 2022;28:1093\u2013107.","journal-title":"CNS Neurosci Ther"},{"key":"418_CR109","doi-asserted-by":"publisher","first-page":"105800","DOI":"10.1016\/j.nbd.2022.105800","volume":"171","author":"Y Li","year":"2022","unstructured":"Li Y, Xia M, Meng S, Wu D, Ling S, Chen X, et al. MicroRNA-29c-3p in dual-labeled exosome is a potential diagnostic marker of subjective cognitive decline. Neurobiol Dis. 2022;171:105800.","journal-title":"Neurobiol Dis"},{"key":"418_CR110","doi-asserted-by":"publisher","first-page":"133","DOI":"10.20517\/evcna.2023.13","volume":"4","author":"E Eitan","year":"2023","unstructured":"Eitan E, Thornton-Wells T, Elgart K, Erden E, Gershun E, Levine A, et al. Synaptic proteins in neuron-derived extracellular vesicles as biomarkers for Alzheimer\u2019s disease: novel methodology and clinical proof of concept. Extracell Vesicles Circ Nucl Acids. 2023;4:133\u201350.","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"key":"418_CR111","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/alz.12723","volume":"19","author":"C Tian","year":"2023","unstructured":"Tian C, Stewart T, Hong Z, Guo Z, Aro P, Soltys D, et al. Blood extracellular vesicles carrying synaptic function- and brain-related proteins as potential biomarkers for Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2023;19:909\u201323.","journal-title":"Alzheimer\u2019s Dement"},{"key":"418_CR112","doi-asserted-by":"crossref","unstructured":"Yu W, Li S, Zhang G, Xu HHK, Zhang K, Bai Y. New frontiers of oral sciences: focus on the source and biomedical application of extracellular vesicles. Front Bioeng Biotechnol. 2022;10:1023700.","DOI":"10.3389\/fbioe.2022.1023700"},{"key":"418_CR113","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neulet.2018.12.030","volume":"696","author":"Z Cao","year":"2019","unstructured":"Cao Z, Wu Y, Liu G, Jiang Y, Wang X, Wang Z, et al. \u03b1-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson\u2019s disease. Neurosci Lett. 2019;696:114\u201320.","journal-title":"Neurosci Lett"},{"key":"418_CR114","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.parkreldis.2019.09.008","volume":"67","author":"K Rani","year":"2019","unstructured":"Rani K, Mukherjee R, Singh E, Kumar S, Sharma V, Vishwakarma P, et al. Neuronal exosomes in saliva of Parkinson\u2019s disease patients: a pilot study. Parkinsonism Relat Disord. 2019;67:21\u20133.","journal-title":"Parkinsonism Relat Disord"},{"key":"418_CR115","doi-asserted-by":"publisher","first-page":"103403","DOI":"10.1016\/j.jprot.2019.103403","volume":"204","author":"D Pieragostino","year":"2019","unstructured":"Pieragostino D, Lanuti P, Cicalini I, Cufaro MC, Ciccocioppo F, Ronci M, et al. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis. J Proteom. 2019;204:103403.","journal-title":"J Proteom"},{"key":"418_CR116","doi-asserted-by":"publisher","first-page":"1809766","DOI":"10.1080\/20013078.2020.1809766","volume":"9","author":"C Soekmadji","year":"2020","unstructured":"Soekmadji C, Li B, Huang Y, Wang H, An T, Liu C, et al. The future of extracellular vesicles as theranostics \u2013 an ISEV meeting report. J Extracell Vesicles. 2020;9:1809766.","journal-title":"J Extracell Vesicles"},{"key":"418_CR117","doi-asserted-by":"publisher","first-page":"e12047","DOI":"10.1002\/jev2.12047","volume":"10","author":"C Han","year":"2021","unstructured":"Han C, Kang H, Yi J, Kang M, Lee H, Kwon Y, et al. Single-vesicle imaging and co-localization analysis for tetraspanin profiling of individual extracellular vesicles. J Extracell Vesicles. 2021;10:e12047.","journal-title":"J Extracell Vesicles"},{"key":"418_CR118","doi-asserted-by":"crossref","unstructured":"Bordanaba-Florit G, Royo F, Kruglik SG, Falc\u00f3n-P\u00e9rez JM. Using single-vesicle technologies to unravel the heterogeneity of extracellular vesicles. Nat Protoc. 2021;16:3163\u201385.","DOI":"10.1038\/s41596-021-00551-z"},{"key":"418_CR119","doi-asserted-by":"crossref","unstructured":"Van Deun J, Mestdagh P, Agostinis P, Akay \u00d6, Anand S, Anckaert J, et al. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat Methods. 2017;14:228\u201332.","DOI":"10.1038\/nmeth.4185"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-024-00418-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-024-00418-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-024-00418-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T17:04:33Z","timestamp":1718816673000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-024-00418-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["418"],"URL":"https:\/\/doi.org\/10.1186\/s40035-024-00418-9","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]},"assertion":[{"value":"15 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}